Ani Pharmaceuticals (ANIP) Free Cash Flow (2016 - 2025)
Historic Free Cash Flow for Ani Pharmaceuticals (ANIP) over the last 17 years, with Q3 2025 value amounting to $38.0 million.
- Ani Pharmaceuticals' Free Cash Flow rose 39532.76% to $38.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $155.7 million, marking a year-over-year increase of 10284.07%. This contributed to the annual value of $47.8 million for FY2024, which is 5659.86% down from last year.
- As of Q3 2025, Ani Pharmaceuticals' Free Cash Flow stood at $38.0 million, which was up 39532.76% from $71.8 million recorded in Q2 2025.
- In the past 5 years, Ani Pharmaceuticals' Free Cash Flow ranged from a high of $71.8 million in Q2 2025 and a low of -$20.9 million during Q1 2022
- Moreover, its 5-year median value for Free Cash Flow was $13.5 million (2024), whereas its average is $13.7 million.
- In the last 5 years, Ani Pharmaceuticals' Free Cash Flow surged by 1157836.26% in 2021 and then plummeted by 175311.14% in 2022.
- Over the past 5 years, Ani Pharmaceuticals' Free Cash Flow (Quarter) stood at -$12.5 million in 2021, then soared by 39.89% to -$7.5 million in 2022, then skyrocketed by 663.29% to $42.5 million in 2023, then plummeted by 68.29% to $13.5 million in 2024, then surged by 181.84% to $38.0 million in 2025.
- Its Free Cash Flow was $38.0 million in Q3 2025, compared to $71.8 million in Q2 2025 and $32.5 million in Q1 2025.